Newsroom | 5864 results

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (“Cresco Labs” or the “Company”), today announced two new additions to its portfolio of leading cannabis brands: High Supply SLIPS—fast-acting oral THC pouches—and Wonder THC Drink Mixes—single-serving beverage packets. The launches reflect the Company's focus on identifying unmet consumer needs, creating new consumer occasions, and developing products that bring new audiences into the regulated cannabis market. “In addition to...

CAMBRIDGE, England--(BUSINESS WIRE)--Amphista Therapeutics Limited (‘Amphista’ or ‘the Company’), a clinical-stage biopharmaceutical company focused on the discovery and development of non-cereblon / VHL targeted protein degradation (TPD) medicines, today announced new data on its lead therapeutic candidate, AMX-883, has been accepted for oral presentation at American Society of Hematology (ASH) Annual Meeting in New Orleans, December 12–15, 2026. The full abstract is available online: www.hema...

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (Nasdaq: DFTX) ("Definium" or the "Company"), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that members of the Company’s management team will participate in the following investor conferences: Stifel 2026 Healthcare Conference Fireside Chat Date and Time: Tuesday, November 10, 2026 at 9:20 AM ET Loc...

LONDON & JERSEY CITY, N.J.--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, today reported the third quarter 2026 financial results and business highlights. "Compass is leading one of the most important advances in mental health care in decades. Millions of people living with TRD are waiting for new treatments that can deliver meaningful and lasting benefit, and we believe COMP360 ha...

BASKING RIDGE, N.J. & MORRISTOWN, N.J.--(BUSINESS WIRE)--Everleap Fertility, a leader in fertility care and assisted reproduction, formerly known as IVI RMA North America, announced today that Dr. Francesca Barrett, a reproductive endocrinologist and infertility specialist, and Dr. Chelsea Manning, a reproductive surgeon, have joined the New Jersey care team at Everleap Fertility. Dr. Manning is now seeing patients at Everleap Fertility, Basking Ridge, Everleap’s flagship clinic, located at 140...

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the results of its annual general and special meeting of shareholders (the “Meeting”) held on October 30, 2026. At the Meeting, shareholders approved three special resolutions relating to: (1) creation of a new parent company (“TopCo”) and exchange of Cresco Labs securities and participating Cresco Labs LLC membership interests for TopCo securities, (2) a potential, s...

TREASURE BEACH, Jamaica--(BUSINESS WIRE)--Psychedelic therapy has a continuity-of-care problem. People often pursue treatment outside their existing mental health care, leaving their therapists disconnected from potentially significant therapeutic experiences. MycoMeditations is working to change that with the Bridge, a new program designed to connect clients’ existing mental health practitioners with the clinical team delivering their psilocybin-assisted therapy in Jamaica. “The person who kno...

韩国首尔--(BUSINESS WIRE)--(美国商业资讯)-- 第14届国际人参研讨会（The Korean Society of Ginseng主办）公布的多项临床与临床前研究表明，红参（Panax ginsengC.A. Meyer）对改善与年龄相关的生理功能衰退具有多方面的作用。相关研究结果涵盖了氧化应激调节、睡眠质量、认知功能衰退、代谢功能障碍以及肌肉功能等多个领域。 由上海交通大学医学院Hong-Sheng Tan教授领导的研究团队，对900名40至75岁自述存在慢性疲劳及免疫功能受损、但无明显器质性疾病的中国成年人进行了评估，旨在评估补充红参对抗氧化能力和整体健康状况的影响。研究显示，作为脂质过氧化及氧化应激生物标志物的血清丙二醛（MDA）水平，在红参组中显著下降，而在安慰剂组中则有所上升。其中，40至60岁受试者的抗氧化作用最为显著，且抗氧化能力与氧化应激水平呈负相关。 在经验证的健康相关生活质量评估工具——36项简明健康状况调查表（SF-36）的八个维度中，红参组的平均得分提高了10.68分，而安慰剂组仅提高了7.13分。其中，在“生理职能”和“活力”两个维度上，两...

韓国ソウル--(BUSINESS WIRE)--（ビジネスワイヤ） -- 第14回国際人参シンポジウム（主催：韓国高麗人参学会）で発表された臨床試験および前臨床試験によると、紅参（Panax ginseng C.A. Meyer）は加齢に伴う生理機能の低下に対して多面的な効果を発揮することが報告されました。その研究結果は、酸化ストレスの調節、睡眠の質、認知機能の低下、代謝機能障害、および筋肉の機能にまで及んでいました。 上海交通大学医学院のホンシェン・タン教授が率いる研究チームは、明らかな器質的疾患はみられないものの、慢性疲労や免疫機能の低下を訴える40歳から75歳の中国人900人を対象に、紅参の摂取が抗酸化能および健康状態に与える影響を評価しました。脂質過酸化反応および酸化ストレスのバイオマーカーである血清マロンジアルデヒド（MDA）は、紅参群では有意に減少した一方、プラセボ群では増加しました。抗酸化作用は40～60歳の参加者で最も顕著にみられ、抗酸化能と酸化ストレスレベルの間には逆相関が認められました。 健康関連の生活の質（QOL）を測定する妥当性が確認された尺度である「Shor...

SEOUL, South Korea--(BUSINESS WIRE)--At the 14th International Symposium on Ginseng, THE Korean Society of Ginseng presented research on red ginseng's anti-aging and cognitive benefits....